Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Amarin Plc Stock Quote

Amarin Plc (NASDAQ: AMRN)

Price as of June 12, 2024, 2:10 p.m. ET

Amarin Plc Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AMRN -39.37% -95.87% -47.14% -100%
S&P +23.89% +85.89% +13.20% +1,094%

Amarin Plc Company Info

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

News & Analysis

The Fool has written over 500 articles on Amarin Plc.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.